Post-market surveillance (PMS) teams operating across global markets receive complaint and adverse event data in multiple languages simultaneously.
When that data arrives in Japanese, German, Portuguese, or French, it waits. Manual triage is almost impossible to scale. Generic AI doesn't meet compliance requirements. The result is delayed signal detection, and in PMS, delays are patient safety risks.
Why Generic AI Cannot Support Post-Market Surveillance Compliance
Every PMS workflow starts the same way: a complaint comes in, an adverse event is reported, a signal begins to form. When that data arrives in a foreign language, it sits in a queue, gets manually translated, and gets interpreted differently depending on who reviews it.
The constraint is well known to quality and regulatory teams. Open-source translation tools and generic AI are not an option. The reasons are consistent across regulated organizations:
-
Data privacy risks
-
Lack of traceability
-
No validation for regulated content
-
Zero audit defensibility
So while AI adoption accelerates across other business functions, PMS teams remain in controlled manual workflows that do not scale. By the time data is ready for triage, time has already been lost, and in PMS, that time directly affects patient safety.
Why 'AI First' Teams Are Still Hitting a Wall
The push toward AI in PMS is real. Signal detection, predictive analytics, automated reporting: all valuable directions. But AI is only as good as the data it understands and the way it is trained.
At a recent Post-Market Surveillance conference in Boston, a leader from a major global medical device manufacturer put it bluntly: "We tried using internal AI to support complaint triage, but it was hallucinating and returning false information. We couldn't trust it, so we couldn't use it."
The underlying issue is structural. Generic AI deployed in PMS typically fails on three counts:
-
Untrained models with no alignment to the device portfolio or risk profile
-
Inconsistent multilingual inputs that distort classification
-
No domain-specific tuning for regulated complaint handling
When inputs are fragmented across languages and misaligned to the product terminology, the AI operates on incomplete or distorted information. The result is not accelerated insight. It is accelerated risk.
What Compliant AI-Assisted Triage Actually Requires
Removing language as a barrier in PMS requires more than speed. It requires AI that can be trusted. Unlike generic or internal tools, Acolad Lia is Acolad's AI translation solution built for regulated content environments. It can be:
-
Trained on the client's own content
-
Aligned to their terminology and product portfolio
-
Controlled within a compliant, auditable environment
This Is Not About Translation. It's About Control
When language stops being a barrier and AI actually understands the business, everything changes across the PMS workflow:
-
Signal detection becomes faster and more reliable
-
Risk assessment becomes more consistent globally
-
AI outputs become trustworthy and actionable
-
Regulatory reporting becomes more defensible
-
Patient communication becomes clearer and more effective
PMS teams move from reacting to problems to controlling them.
"The biggest bottleneck in post-market surveillance isn't a lack of data, it's a lack of understanding. If you can't instantly process and trust what's coming in across markets, you're always reacting. With Lia, we're giving PMS teams the ability to triage, route, and act on global data in real time, in a way that's both scalable and fully compliant."
Joseph Tringale, Senior Business Development Director, Acolad
Key Takeaways
-
Manual translation in PMS creates delays that compound across the full triage chain: classification, routing, signal detection, and regulatory reporting are all affected.
-
Open-source tools and generic AI fail regulated PMS workflows on four counts: privacy exposure, lack of traceability, no content validation, and zero audit defensibility.
-
AI is only as good as the data it understands. Fragmented multilingual inputs and misaligned terminology produce distorted outputs, not accelerated insight.
-
Trustworthy AI-assisted triage in PMS requires domain-specific training, an auditable environment, and terminology locked to the product portfolio.
-
When language stops being a barrier, PMS teams shift from reacting to controlling: faster signal detection, more consistent risk assessment, and more defensible regulatory reporting.
